High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. Oxombre B, Lee-Chang C, Duhamel A, Toussaint M, Giroux M, Donnier-Marechal M, Carato P, Lefranc D, Zephir H, Prin L, Melnyk P, & Vermersch P Br. J. Pharmacol., 172:1769-1782, 2015.
High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis [link]Paper  doi  bibtex   
@article{oxombre_b_high-affinity_2015,
title = {High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis},
volume = {172},
issn = {0007-1188},
url = {http://www.ncbi.nlm.nih.gov/pubmed/25521311},
DOI = {10.1111/bph.13037},
Language = {English},
Journal = {Br. J. Pharmacol.},
author = {{Oxombre B} and {Lee-Chang C} and {Duhamel A} and {Toussaint M} and {Giroux M} and {Donnier-Marechal M} and {Carato P} and {Lefranc D} and {Zephir H} and {Prin L} and {Melnyk P} and {Vermersch P}},
year = {2015},
keywords = {Animals, B-Lymphocytes/immunology, Brain/drug effects, Brain/pathology, Cytokines/blood, Encephalomyelitis, Autoimmune, Experimental/blood, Encephalomyelitis, Autoimmune, Experimental/drug therapy*, Encephalomyelitis, Autoimmune, Experimental/immunology, Encephalomyelitis, Autoimmune, Experimental/pathology, Female, Immunoglobulin G/blood, Lymph Nodes/drug effects, Lymph Nodes/immunology, Mice, Multiple Sclerosis/blood, Multiple Sclerosis/drug therapy*, Multiple Sclerosis/immunology, Multiple Sclerosis/pathology, Myelin Proteolipid Protein/immunology, Neuroprotective Agents/pharmacology, Neuroprotective Agents/therapeutic use*, Peptide Fragments/immunology, Receptors, sigma/agonists*, Spinal Cord/drug effects, Spinal Cord/pathology, Spleen/drug effects, Spleen/immunology, T-Lymphocytes, Regulatory/immunology},
pages = {1769-1782}
}

Downloads: 0